Skip to main content

View full-text article in PMC

letter

. 2020 Jun 3;21:459. doi: 10.1186/s13063-020-04404-0

Table 3.

Primary and secondary results of the GKT137831 trial

Outcome		Analysis	Mean (standard deviation)		Estimated mean difference^a	95% Confidence Interval	P value
Outcome		Analysis	Intervention (GKT137831) group (n = xxx)	Placebo group (n = xxx)	Estimated mean difference^a	95% Confidence Interval	P value
Primary	Endpoint UACR	Intention to treat (ITT)
		modified ITT
		Per protocol (PP)
Secondary	Midpoint UACR	Intention to treat (ITT)
		modified ITT
		Per protocol (PP)
	Endpoint eGFR	Intention to treat (ITT)
		modified ITT
		Per protocol (PP)
	Midpoint eGFR	Intention to treat (ITT)
		modified ITT
		Per protocol (PP)

UACR urine albumin: creatinine ratio, eGFR estimated glomerular filtration rate

^a In the intervention group compared to placebo